G Klintmalm
About
In The Last Decade
G Klintmalm
35 papers receiving 624 citations
Peers
Comparison fields: 5 of 70
- Hepatology 305
- Surgery 250
- Epidemiology 232
- Transplantation 149
- Oncology 114
Countries citing papers authored by G Klintmalm
This map shows the geographic impact of G Klintmalm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Klintmalm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Klintmalm more than expected).
Fields of papers citing papers by G Klintmalm
This network shows the impact of papers produced by G Klintmalm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Klintmalm. The network helps show where G Klintmalm may publish in the future.
Co-authorship network of co-authors of G Klintmalm
This figure shows the co-authorship network connecting the top 25 collaborators of G Klintmalm. A scholar is included among the top collaborators of G Klintmalm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Klintmalm. G Klintmalm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 23 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 65 | |
| 6 | 26 | |
| 7 | 23 | |
| 8 | Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: Preliminary results from US multicenter trial | 16 |
| 9 | 1 | |
| 10 | Prognostic factors for successful conversion from cyclosporine to FK 506- based immunosuppressive therapy for refractory rejection after liver transplantation | 15 |
| 11 | Rejection: FK 506 for rescue or maintenance. | 1 |
| 12 | Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection | 7 |
| 13 | 4 | |
| 14 | FK 506 rescue therapy in liver transplantation: outcome and complications. | 19 |
| 15 | 173 | |
| 16 | DHPG (Gancyclovir) improves survival in CMV pneumonia. | 7 |
| 17 | Long term nephrotoxicity in liver transplantation. | 7 |
| 18 | Incidence and outcome of acute rejection in liver transplantation. | 3 |
| 19 | HLA-matching in cyclosporine treated renal transplant recipients: a prospective Swedish-Norwegian multicenter study. | 0 |
| 20 | Effect of complete biliary-tract obstruction on serial hepatobiliary imaging in an experimental model: concise communication. | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.